Erythropoietin: Recent Developments in the Treatment of Spinal Cord Injury

@inproceedings{Carelli2011ErythropoietinRD,
  title={Erythropoietin: Recent Developments in the Treatment of Spinal Cord Injury},
  author={Stephana Carelli and Giovanni Marfia and Anna Maria Di Giulio and Giorgio Ghilardi and Alfredo Gorio},
  booktitle={Neurology research international},
  year={2011}
}
Erythropoietin (EPO), originally identified for its critical function in regulating production and survival of erythrocytes, is a member of the type 1 cytokine superfamily. Recent studies have shown that EPO has cytoprotective effects in a wide variety of cells and tissues. Here is presented the analysis of EPO effects on spinal cord injury (SCI), considering both animal experiments concerning to mechanisms of neurodegeneration in SCI and EPO as a neuroprotective agent, and some evidences… CONTINUE READING